Scinder Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in New Delhi, Delhi, India, established in 2015.
2015 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Scinder Pharmaceuticals Private Limited

Scinder Pharmaceuticals Private Limited, a active private limited company, was established on 23 June 2015 in New Delhi, Delhi, India. Engaging in wholesale within the trade sector, it holds CIN: U51101DL2015PTC281891. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Mahak Ruhela (Director), Nitesh Rohilla (Director). Past directors included Mahak Ruhela, Kaleem Ahmad. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 9-A, Shivpuri Road Shivpuri Extension, New Delhi, Delhi, 110051.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51101DL2015PTC281891

  • Registration Number

    281891

  • Incorporation Date

    23 June 2015

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 7 Months
  • Last Filing with ROC 31 Mar 2023
Company report

Scinder Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Scinder Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Scinder Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Mahak Ruhela Director 18 Sep 2020 Current
Nitesh Rohilla Director 23 Jun 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 31 Dec 2020 Past
Pramod Abcsdd Director 21 Sep 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Scinder Pharmaceuticals.

Scinder Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Scinder Pharmaceuticals revenue growth over time
Scinder Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Scinder Pharmaceuticals?

In 2017, Scinder Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Scinder Pharmaceuticals?

Unlock and access historical data on people associated with Scinder Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Scinder Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scinder Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Scinder Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Scinder Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Scinder Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was completed.

  • Director Appointment

    The activity Mahak Ruhela was appointed as a Director was appointed as a Director on 18 Sep 2020 & has been associated with this company since 5 years 4 months . was completed.

  • Director Appointment

    The activity Nitesh Rohilla was appointed as a Director was appointed as a Director on 23 Jun 2015 & has been associated with this company since 10 years 7 months . was completed.

  • Company Incorporation

    The activity Scinder Pharmaceuticals Private Limited was registered on 23 Jun 2015 with Roc Delhi & aged 10 years 7 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Scinder Pharmaceuticals Private Limited?

The CIN of Scinder Pharmaceuticals Private Limited is U51101DL2015PTC281891.

Where is Scinder Pharmaceuticals Private Limited headquartered?

Scinder Pharmaceuticals Private Limited is headquartered at 9-A, Shivpuri Road Shivpuri Extension, New Delhi, Delhi, 110051.

When was Scinder Pharmaceuticals Private Limited incorporated?

Scinder Pharmaceuticals Private Limited was incorporated on 23 June 2015.

Who are the current directors of Scinder Pharmaceuticals Private Limited?

The current directors of Scinder Pharmaceuticals Private Limited are

What is the primary industry of Scinder Pharmaceuticals Private Limited?

The primary industry of Scinder Pharmaceuticals Private Limited is Trade.

Is Scinder Pharmaceuticals Private Limited a listed company?

Scinder Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Scinder Pharmaceuticals Private Limited?

The authorized capital of Scinder Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Scinder Pharmaceuticals Private Limited?

The compliance status of Scinder Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available